Wobenzym (Systemic Enzymes).

Bromelain is one of the plant proteases these systemic enzyme blends are built around, working alongside pancreatic trypsin and chymotrypsin. Adding more of it strengthens the same proteolytic activity rather than introducing a new one.

Serrapeptase is a bacterial protease with activity against extracellular protein and fibrin-like substrate. It is layered onto plant and pancreatic proteases in the same blends because the enzymes have different substrate preferences.

Nattokinase has direct fibrinolytic activity and these proteolytic blends act on fibrin and plasmin regulation as well. Combining them pushes normal clot breakdown further in one direction, so the pairing is recorded as an additive one.

Systemic enzyme blends classically pair proteases with rutin, a quercetin glycoside, for its action on capillary integrity and mast cell mediator release. Quercetin is the aglycone of that same flavonoid and is used the same way.

Bromelain-containing protease blends are routinely combined with curcumin, where the enzymes are used to aid uptake of the poorly absorbed polyphenol. Both also act on NF-kB driven mediator production.

Boswellic acids act on 5-lipoxygenase and the leukotriene arm, while proteolytic blends act on circulating protein complexes and on kinin generation. The targets are separate points in one mediator cascade.

EPA reduces platelet aggregation by displacing arachidonic acid from the thromboxane pathway, and proteolytic enzyme blends act on fibrin turnover. The two arms of normal clot formation are affected at once.

Ginkgolides antagonise platelet activating factor while the enzyme blend acts on fibrin. Stacking them affects platelet activation and fibrin breakdown together.

Higher intakes of alpha-tocopherol interfere with vitamin K dependent clotting factor activity and with platelet adhesion. Layered onto a fibrinolytic enzyme blend the effects on normal clotting add.

Papain is a cysteine protease with a broad substrate range and a different cleavage preference from bromelain and trypsin. Blends carry several proteases precisely because no single one covers every bond.

Rutin is part of the traditional hydrolytic enzyme and flavonoid combination rather than an added partner, so a formula that already contains this blend is carrying rutin. Trials of the combination test enzymes plus flavonoid together and cannot separate the two contributions. Do not count rutin twice across a stack.

Pancreatic trypsin and chymotrypsin are among the proteases in the classic systemic enzyme blend, so adding a separate pancreatin product raises the same protease load. This matters for dose accounting rather than adding a new mechanism. Both are porcine-derived unless stated otherwise.

Digestive enzyme blends are designed to act on a meal in the gut lumen, while systemic enzyme products are enteric-coated to pass the stomach and be taken away from food. Combining them muddles both intents and can mean the systemic product is used up on dietary protein. Timing is the whole distinction here.

Betaine hydrochloride is taken to lower stomach pH, and proteolytic enzymes lose activity at low pH, which is precisely why systemic enzyme products are enteric coated. Taking the two together works against the coating's purpose. Separate them in time rather than combining in one serving.

Bicarbonate raises gastric pH, which can trigger an enteric coating to open earlier than designed. That means release in the stomach rather than the small intestine. It is a formulation timing interaction, and the practical answer is spacing the doses.

Garlic constituents reduce platelet aggregation in human studies, and proteolytic enzyme blends are used with attention to fibrinolytic and coagulation markers. Stacking them is an additive platelet-effect consideration, especially around surgery or with anticoagulant medication. Anyone in that situation should raise it with their prescriber.

Salicin from willow bark is converted to salicylate, which affects platelet function by the same general route as aspirin. Combined with a systemic enzyme product the platelet effect is additive. Flagged as a caution rather than a benefit.

Gingerols have been reported to reduce platelet aggregation in human and ex vivo work, though results across studies are inconsistent. Alongside proteolytic enzymes this is an additive consideration to note before a procedure. The inconsistency in the data is part of the honest picture.

The classic hydrolytic enzyme formulation already pairs proteases with a flavonoid, and proanthocyanidin extracts are used in the same role in modern blends. The pairing follows formulation convention rather than a study of that specific combination. Flavonoids also carry their own mild platelet effects.

Pine bark proanthocyanidins are used in the same flavonoid slot as rutin in enzyme-flavonoid blends. The rationale is class-based, not a tested combination with this enzyme mix. Doses and standardisation differ enough between flavonoid sources that they are not interchangeable on label weight.

Glucosamine supplies an amino sugar precursor for glycosaminoglycan synthesis, an entirely different route from proteolysis. Products aimed at joint comfort and mobility often carry both. There is no trial of the pair, and glucosamine sulfate is usually shellfish-derived, which is an allergen to declare.

Chondroitin is a large sulfated glycosaminoglycan with its own absorption limits, used alongside enzymes in joint comfort formulas. Proteases act on peptide bonds and would not degrade a glycosaminoglycan, so there is no chemical conflict. The combination itself is untested.

Collagen peptides are protein, and a protease released into the small intestine will act on protein it encounters, including a co-taken peptide dose. Taking a systemic enzyme product away from protein is the standard instruction for exactly this reason. Space them rather than combining in one serving.

An enteric-coated protease released alongside a large protein bolus will spend its activity on that protein. The whole point of dosing systemic enzymes away from food is to avoid this. Not harmful, just self-defeating.

Hyaluronic acid is a non-sulfated glycosaminoglycan taken for tissue hydration and joint comfort, unaffected by protease activity. It appears with enzymes in the same product category. No combination data exists and the pairing is a formulation choice.

Several proteases including carboxypeptidase are zinc metalloenzymes and lose activity without the metal ion. That is intrinsic enzyme chemistry rather than a reason to co-dose, since the enzyme arrives with its own metal. Worth stating so nobody claims zinc boosts a systemic enzyme product.

Resveratrol reduces platelet aggregation in laboratory work and is used in the same formula category. Combined with proteolytic enzymes the platelet consideration is additive. The human significance at supplement doses is not established.